Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-C motif chemokine ligand 25 is a small cytokine in the CC chemokine family, also known as thymus-expressed chemokine (TECK), encoded by the CCL25 gene on chromosome 19[1][2][3][6]. It is primarily involved in the development of T-cells, acting as a chemotactic factor for thymocytes, macrophages, and dendritic cells, and functions by binding to the CCR9 receptor[1]. CCL25 also demonstrates antimicrobial effects against pathogens such as E. coli and S. aureus and plays a regulatory role in immunity and disease contexts such as colorectal cancer[5].
Ligand for CCR9 chemokine receptor, mediating chemotaxis and immune cell migration
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C motif chemokine ligand 25 (CCL25).